Blunt Roy sold $293K of THC

Blunt Roy sold 1,000 shares of TENET HEALTHCARE CORP (THC) at $293.00 ($0.29M total) on 2026-11-11.

Original reporting
SEC EDGAR · Blunt Roy
Published Nov 14, 2026, 1:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 14, 2026, 1:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$THC
Bearish
medium confidence
Mentioned
$THC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCBearishLow
01

Why it matters

A small insider sale by a director is disclosed as a routine corporate event with limited market impact.

02

Market read

Routine insider sale with modest potential to cause slight short-term pressure; unlikely to drive significant price movement.

03

What to watch

The director's overall holdings remain sizable, reducing the significance of the sale.

Relevance 4/10Novelty 4/10Timing: after-hours filing

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$THCBearishMedium confidence
Context

Director Blunt Roy sold 1,000 shares for $293,000, reducing his stake to 3,589 shares.

Expected impact

potential modest pressure as the market prices in the insider sell

Evidence & confidence

The sale is small relative to total float and likely has limited impact, but insider sales can prompt short-term selling pressure.

Market effects

Minimal effect on healthcare sector; typical insider transaction.

None

None

Counterpoint

The sale may be routine and not indicative of any underlying issues.

Key entities

  • Tenet Healthcare Corp

    US-listed healthcare services provider (ticker THC).

  • Blunt Roy

    Director of Tenet Healthcare who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$THCHighAI 8/10

Mizuho raises Tenet Healthcare stock price target on strong results

Mizuho increased its price target for Tenet Healthcare (NYSE:THC) to $305 from $290, citing strong quarterly results and raised 2026 EBITDA estimates. The stock trades near its 52-week high after a 49% six-month surge. Tenet reported Q3 2026 EPS of $6.64, beating estimates, and raised its full-year EBITDA outlook. Guggenheim maintained a Buy rating with a slightly lowered target of $306.

$THCMed

Tenet Healthcare Q3 Earnings Call Highlights

Tenet Healthcare (THC) reported Q3 earnings, with hospital segment showing 3.2% growth in admissions and 11% adjusted EBITDA increase. Revenue per admission rose 0.2% YoY. Exchange admissions and revenues declined 18%. Conifer transition activities contributed $147M, with $450M expected in 2026. Tenet generated $1.1B in adjusted free cash flow and repurchased 970K shares.